A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer
Lok, Sheau W, Whittle, James R, Vaillant, François, Teh, Charis E, Lo, Louisa L, Policheni, Antonia N, Bergin, Alice R T, Desai, Jayesh, Ftouni, Sarah, Gandolfo, Luke C, Liew, Danny, Liu, He K, Mann, G Bruce, Moodie, Kate, Murugasu, Anand, Pal, Bhupinder, Roberts, Andrew W, Rosenthal, Mark A, Shackleton, Kylie, Silva, Maria João, Siow, Zhen R, Smyth, Gordon K, Taylor, Leanne, Travers, Avraham, Yeo, Belinda, Yeung, Miriam M, Bujak, Andjelija Zivanovic, Dawson, Sarah-Jane, Gray, Daniel H D, Visvader, Jane E, Lindeman, Geoffrey J
Published in Cancer discovery (01.03.2019)
Published in Cancer discovery (01.03.2019)
Get full text
Journal Article